176 results
Page 3 of 9
8-K
EX-99.1
tadid 0vrpp4n
15 May 23
Checkpoint Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
4:21pm
8-K
EX-10.1
miy4o k8v
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
8-K
EX-99.1
350g3o
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
8-K
EX-99.1
497xujce 2ft5qmwvx
31 Mar 23
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
6:00am
8-K
EX-10.1
0i7hdw9igl2 7kzsje
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
8-K
EX-99.1
q4aezv9tmhmydu5 1u
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
8-K
EX-99.1
gqonpxl8fcmlcelw
5 Dec 22
Checkpoint Therapeutics Announces Reverse Stock Split
4:45pm
DEF 14C
8enegg5u625omycdc
14 Nov 22
Information statement
5:00pm
8-K
EX-99.1
3xdwl69ov0f3ti9k8f
8 Nov 22
Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
5:43pm
PRE 14C
3078msl7u orr
4 Nov 22
Preliminary information
5:22pm